Enabling Immunotherapy Responses in Solid Tumours Through Engineered Microbial Based Therapeutics
Time: 2:00 pm
day: Focus Day
Details:
- Treating immunotherapy non-responders by targeting the extracellular matrix which acts as a physical barriers to effective immune infiltration to the tumour core
- Harnessing tumour colonising bacteria to locally disrupt the tumour extracellular matrix from within
- Adopting bacterial engineering approaches
